trial

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

NCTId NCT02160249
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 166 (actual)
Sponsored by London School of Hygiene and Tropical Medicine
Primary completion 2017-03-26
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
166 (actual)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
Single
Start
2015-09
Primary completion
2017-03-26
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Community-based rehabilitationFacility based care

Sponsors

London School of Hygiene and Tropical MedicineLead Sponsor
Addis Ababa UniversityCollaborator

Investigators

2
Mary De Silva, PhD MScPrincipal Investigator
Abebaw Fekadu, MD, PhDPrincipal Investigator

Sites

1 total
Addis Ababa, Ethiopia

Facts & assertions

4 sourced
Enrollment
166
Phase
NA
Primary Completion Date
2017-03-26
Status
COMPLETED
relationships
The graph out of here
drug
Community-based rehabilitation
drug
Facility based care
drug
lead_sponsor
London School of Hygiene and Tropical Medicine
company
collaborator
Addis Ababa University
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Schizophrenia Spectrum Disorder
indication
investigator
Mary De Silva, PhD MSc
person
Abebaw Fekadu, MD, PhD
person